spacer
home > ebr > autumn 2018 > protein progression
PUBLICATIONS
European Biopharmaceutical Review

Protein Progression

Microarrays offer a well-established bioanalytical format for high-throughput studies of many different biomolecules. In the field of peptide and protein microarrays, great progress has been achieved in immobilising large numbers of native target molecules, such as recombinant human proteins or peptide libraries to microarray surfaces. With an increased content at high quality, protein and peptide microarrays offer new possibilities in proteomics and pharmaceutical R&D. Simultaneously, label-free sensing has evolved from highly sophisticated, but low-throughput, to powerful multiplexed screening tools. The combination of these advancements opens a new field of bioanalytics.

Analysis at a Glance

Proteins are involved in almost any process of a living cell. Therefore, proteomics is a key discipline of modern life sciences today. Furthermore, protein-protein interactions of human cells (the so-called human interactome, see Figure 1) and the interactions of proteins with other biomolecules are key for understanding any physiological process and manipulating it (eg, by a pharmaceutical or biopharmaceutical drug).

Protein scientists have developed different bioanalytical approaches based on proteins immobilised in a microarray format. Here, the focus lies on protein microarrays representing a set of species-specific (in most cases, human) proteins to study the binding of a specific molecule or sample to these target proteins in a single assay. The trend is towards a fraction up to the complete genetically encoded proteome.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Güenther Proll is Co-Founder and Managing Director at Biametrics and has more than 18 years’ experience in optical biosensing. Güenther’s work is focussed on the characterisation and development of optical transduction technologies, spatially resolved surface chemistry on diverse substrates, and multianalyte/multiplex assay developments. He holds a diploma in technical biology from the University of Stuttgart, Germany, and a PhD in physical chemistry from the University of Tuebingen, Germany.
spacer
Dr Güenther Proll
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement